The human sebocyte culture model provides new insights into development and management of seborrhoea and acne

Dermatology

Volumn 196, Issue 1, 1998, Pages 21-31

  Zouboulis, Christos C ^a   Xia, L ^a   Akamatsu, H ^a   Seltmann, H ^a   Fritsch, M ^a   Hornemann, S ^a   Ruhl R ^b   Chen, W ^a   Nau, H ^b   Orfanos, C E ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

5 reductase; 5 reductase inhibitors; Acne; Androgens; Anti androgens; Cultured cells, in vitro; Immunology; Interleukin 1; Physiology; Retinoids; Sebaceous gland; Seborrhoea; Vitamin A

Indexed keywords

4,7BETA DIMETHYL 4 AZACHOLESTAN 3 ONE; ANDROGEN; ANDROSTANEDIOL; ANDROSTANOLONE; ANDROSTENEDIONE; ANDROSTERONE; FATTY ACID; FINASTERIDE; HYDROCORTISONE; INSULIN; INTERLEUKIN 1ALPHA; ISOTRETINOIN; LIPID; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROTEIN; RETINOID; RETINOL; SPIRONOLACTONE; STEROID 5ALPHA REDUCTASE; TESTOSTERONE; THYROTROPIN;

ACNE; CELL ACTIVITY; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; FATTY ACID SYNTHESIS; HORMONAL REGULATION; HORMONE METABOLISM; HUMAN; HUMAN CELL; LIPOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEBACEOUS CELL; SEBACEOUS GLAND; SEBORRHEA;

ACNE VULGARIS; ANDROGENS; CELL DIVISION; CELLS, CULTURED; DERMATITIS, SEBORRHEIC; HUMANS; RETINOIDS; SEBACEOUS GLANDS;

EID: 0031881982     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017861     Document Type: Conference Paper

References (77)

1. Cunliffe WJ: Acne. London, Dunitz, 1989.
2. Oshima S: An approach for the treatment of acne vulgaris: Global development of a anti-acne drug. Abstr 22nd Annu Meet Jpn Cosmet Sci Soc, Tokyo, 1997, pp 25-26.
3. Gollnick H, Zouboulis ChC, Akamatsu H, Kurokawa I, Schulte A: Pathogenesis and pathogenesis related treatment of acne. J Dermatol 1991;18:489-499.
4. Harris HH, Downing DT, Stewart ME, Strauss JS: Sustainable rates of sebum secretion in acne patients and matched normal control subjects. J Am Acad Dermatol 1983;8:200-203.
5. Piérard GE, Piérard-Franchimont C, Le T: Seborrhoea in acne-prone and acne-free patients. Dermatologica 1987;175:5-9.
6. Thody AJ, Shuster S: Control and function of sebaceous glands. Physiol Rev 1989;69:383-416.
7. Geiger J-M: Retinoids and sebaceous gland activity. Dermatology 1995;191:305-310.
8. Pochi P: Sebaceous gland assay; in Lowe N, Maibach H (eds): Models in Dermatology. Basel, Karger, 1985, vol 2, pp 70-75.
9. Shapiro SS, Hurley J, Vane FM, Doran T: Evaluation of potential therapeutic entities for the treatment of acne; in Reichert U, Schroot B (eds): Pharmacology of Retinoids in the Skin. Pharmacol Skin. Basel, Karger, 1989, vol 3, pp 104-112.
10. Nikkari T: Comparative chemistry of sebum. J Invest Dermatol 1974;62:257-267.
11. 14C by suction blister epidermis and other skin components. Proc Soc Exp Biol Med 1970;135:285-291.
12. Cooper MF, McGrath H, Shuster S: Sebaceous lipogenesis in human skin. Variability with age and severity of acne. Br J Dermatol 1976;94:165-172.
13. Sharp F, Hay JB, Hodgins MB: Metabolism of androgens in vitro by human foetal skin. J Endocrinol 1976;70:491-499.
14. Petersen MJ, Zone JJ, Krueger GG: Development of a nude mouse model to study human sebaceous gland physiology and pathophysiology. J Clin Invest 1984;74:1358-1365.
15. Kealey T, Lee CM, Thody AJ, Coaker T: The isolation of human sebaceous glands and apocrine sweat glands by shearing. Br J Dermatol 1986;114:181-188.
16. Sanders DA, Philpott MP, Nicolle FV, Kealey T: The isolation and maintenance of the human pilosebaceous unit. Br J Dermatol 1994;131:166-176.
17. Xia L, Zouboulis Ch, Detmar M, Mayer-da-Silva A, Stadler R, Orfanos CE: Isolation of human sebaceous glands and cultivation of sebaceous gland-derived cells as an in vitro model. J Invest Dermatol 1989;93:315-321.
18. Karasek MA, Charlton ME: In vitro growth and serial cultivation of normal human sebaceous gland cells. Clin Res 1982;30:263A.
19. Karasek M: Isolation and characterization of cells from the human sebaceous gland. In Vitro, 1986;22(part II):22A.
20. Doran TI, Baff R, Jacobs P, Pacia E: Characterization of human sebaceous cells in vitro. J Invest Dermatol 1991;96:341-348.
21. Zouboulis ChC, Xia L, Detmar M, Bogdanoff B, Giannakopoulos G, Gollnick H, Orfanos CE: Culture of human sebocytes and markers of sebocytic differentiation in vitro. Skin Pharmacol 1991;4:74-83.
22. Lee CM: Cell culture systems for the study of human skin and skin glands; in Jones CJ (ed): Epithelia: Advances in Cell Physiology and Cell Culture. Dordrecht, Kluwer, 1990, pp 333-350.
23. Akamatsu H, Zouboulis ChC, Orfanos CE: Control of human sebocyte proliferation in vitro by testosterone and 5-alpha-dihydrotestosterone is dependent on the localization of the sebaceous glands. J Invest Dermatol 1992;99:509-511.
24. Akamatsu H, Zouboulis ChC, Orfanos CE: Spironolactone directly inhibits proliferation of cultured human facial sebocytes and acts antagonistically to testosterone and 5-alpha-dihydrotestosterone in vitro. J Invest Dermatol 1993;100:660-662.
25. Zouboulis ChC, Korge BP, Mischke D, Orfanos CE: Altered proliferation, synthetic activity, and differentiation of cultured human sebocytes in the absence of vitamin A and their modulation by synthetic retinoids. J Invest Dermatol 1993;101:628-633.
26. Fujie T, Shikiji T, Uchida N, Urano Y, Nagae H, Arase S: Culture of cells derived from the human sebaceous gland under serum-free conditions without a biological feeder layer or specific matrices. Arch Dermatol Res 1996;288:703-708.
27. Imagawa W, Cunha GR, Young P, Nandi S: Keratinocyte growth factor and acidic fibroblast growth factor are mitogens for primary cultures of mammary epithelium. Biochem Biophys Res Commun 1994;204:1165-1169.
28. Seltmann H, Rühl R, Seiffert K, Plum C, Orfanos CE, Nau H, Zouboulis ChC: Isotretinoin treatment of human sebocytes in vitro results in low isotretínoin, but considerably elevated tretinoin intracellular levels and its effect is not affected by the presence of retinol. J Invest Dermatol 1997;108:374.
29. Chen W, Zouboulis ChC, Fritsch M, Blume-Peytavi U, Kodelja V, Goerdt S, Luu-The V, Orfanos CE: Evidence of heterogeneity and quantitative differences of the type 1 5α-reductase expression in cultured human skin cells: Evidence of its presence in melanocytes. J Invest Dermatol, in press.
30. Zouboulis ChC, Xia L, Korge B, Gollnick H, Orfanos CE: Cultivation of human sebocytes in vitro: Cell characterization and influence of synthetic retinoids; in Saurat J-H (ed): Retinoids: 10 Years On. Basel, Karger, 1991, pp 254-273.
31. Zouboulis ChC, Krieter A, Gollnick H, Mischke D, Orfanos CE: Progressive differentiation of human sebocytes in vitro is characterized by increasing cell size and altering antigen expression and is regulated by culture duration and retinoids. Exp Dermatol 1994;2:151-160.
32. Zouboulis ChC: Sebaceous cells in monolayer culture. In Vitro Cell Dev Biol 1992;28A:699.
33. Doran TI, Lucas DA, Levin AA, Pacia E, Sturzenbecker L, Allenby G, Grippo JF, Shapiro SS: Biochemical and retinoid receptor activities in human sebaceous cells; in Saurat J-H (ed): Retinoids: 10 Years On. Basel, Karger, 1991, pp 243-253.
34. Tosti A: A comparison of the histodynamics of sebaceous glands and epidermis in man: A microanatomic and morphometric study. J Invest Dermatol 1974;62:147-152.
35. McEwan Jenkinson D, Elder HY, Montgomery I, Moss VA: Comparative studies of the ultrastructure of the sebaceous gland. Tissue Cell 1985;17:683-698.
36. Cassidy DM, Lee CM, Laker MF, Kealey T: Lipogenesis in isolated sebaceous glands. FEBS Lett 1986;200:173-176.
37. Ridden J, Ferguson D, Kealy T: Organ maintenance of human sebaceous glands: In vitro effects of 13-cis-retinoic acid and testosterone. J Cell Sci 1990;95:125-136.
38. Akai Y, Akamatsu H, Ri S, Ito A, Zouboulis ChC, Asada Y: Influence of free fatty acids on the proliferation of cultured human sebocytes in vitro. Jpn J Dermatol 1994;104:647-649.
39. Boehm KD, Yun JK, Strohl KP, Elmets CA: Messenger RNAs for the multifunctional cytokines interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor-alpha are present in adnexal tissues and in dermis of normal human skin. Exp Dermatol 1995;4:335-341.
40. Eady EA, Ingham E, Walters CE, Cove JH, Cunliffe WJ: Modulation of comedonal levels of interleukin-1 in acne patients treated with tetracyclines. J Invest Dermatol 1993;101:86-91.
41. Ingham E, Eady EA, Goodwin CE, Cove JH, Cunliffe WJ: Pro-inflammatory levels of interleukin-1α-like bioactivity are present in the majority of open comedones in acne vulgaris. J Invest Dermatol 1992;98:895-901.
42. Guy R, Green MR, Kealey T: Modeling acne in vitro. J Invest Dermatol 1996;106:176-182.
43. Hornemann S, Seltmann H, Kodelja V, Orfanos CE, Zouboulis ChC: Interleukin 1α mRNA and protein are expressed in cultured human sebocytes at steady state and their levels are barely influenced by lipopolysaccharides. J Invest Dermatol 1997;108:382.
44. Ingham E, Walters CE, Eady EA, Cove JH, Kearney JN, Cunliffe WJ: Inflammation in acne vulgaris - Failure of skin micro-organisms to modulate keratinocyte IL-1α production in vitro. J Invest Dermatol 1997;108:382.
45. Chen W-C, Zouboulis ChC, Orfanos CE: The 5α-reductase system and its inhibitors: Recent development and its perspective in treating androgen-dependent skin disorders. Dermatology 1996;193:177-184.
46. Thigpen AE, Silver RI, Guileyardo JM, Casey ML, McConnell JD, Russell DW: Tissue distribution and ontogeny of steroid 5α-reductase isozyme expression. J Clin Invest 1993;92:903-910.
47. Luu-The V, Sugimoto Y, Puy L, Labrie Y, Lopez-Solache I, Singh M, Labrie F: Characterization, expression, and immunohistochemical localization of 5-alpha-reductase in human skin. J Invest Dermatol 1994;102:221-226.
48. Eicheler W, Dreher M, Hoffmann R, Happle R, Aumüller G: Immunohistochemical evidence for differential distribution of 5α-reductase isoenzymes in human skin. Br J Dermatol 1995;133:371-376.
49. Thiboutot D, Harris G, Iles V, Cimis G, Gilliland K, Hagari S: Activity of the type 1 5-alpha-reductase exhibits regional differences in isolated sebaceous glands and whole skin. J Invest Dermatol 1995;105:209-214.
50. Sawaya ME: Purification of androgen receptors in human sebocytes and hair. J Invest Dermatol 1992;98(suppl):92S-96S.
51. Bläuer M, Vaalasti A, Pauli S-L, Ylikomi T, Joensuu T, Tuohimaa P: Location of androgen receptor in human skin. J Invest Dermatol 1991;97:264-268.
52. Choudhry R, Hodgins MB, Van der Kwast TH, Brinkmann AO, Boersma WJ: Localization of androgen receptors in human skin by immunohistochemistry: implications for the hormonal regulation of hair growth, sebaceous glands and sweat glands. J Endocrinol 1992;133:467-475.
53. Liang T, Hoyer S, Yu R, Soltani K, Lorincz AL, Hiipakka RA, Liao S; Immunocytochemical localization of androgen receptors in human skin using monoclonal antibodies against the androgen receptor. J Invest Dermatol 1993;100:663-666.
54. Sawaya ME, Honig LS, Hsia SL: Increased androgen binding capacity in sebaceous glands in scalp of male-pattern baldness. J Invest Dermatol 1988;92:91-95.
55. Sabouraud R: Maladies du cuir chevelu. I. Les maladies séborrhéiques. Séborrhée, acnés, calvitie. Paris, Masson et Cie, 1902.
56. Zouboulis ChC, Akamatsu H, Stephanek K, Orfanos CE: Androgens affect the activity of human sebocytes in culture in a manner dependent on the localization of the sebaceous glands and their effect is antagonized by spironolactone. Skin Pharmacol 1994;7:33-40.
57. Fritsch M, Seltmann H, Orfanos CE, Zouboulis ChC: 5α-Reductase type I inhibitor MK386 exhibits a markedly stronger activity on testosterone metabolism than type II inhibitor dihydrofinasteride in human sebocytes and keratinocytes in vitro. J Invest Dermatol 1997;108:378.
58. Gollnick HPM: The treatment of acne. Drugs Today 1992;28:353-361.
59. Ellsworth K, Azzolina B, Baginsky W, Bull H, Chang B, Cimis G, Mitra S, Toney J, Bakshi RK, Rasmusson GR, Tolman RL, Harris GS: MK386: A potent, selective inhibitor of the human type 1 5αlpha-reductase. J Steroid Biochem Mol Biol 1996;58:377-384.
60. Orfanos CE, Zouboulis ChC, Almond-Roesler B, Geilen CC: Current use and future potential role of retinoids in dermatology. Drugs 1997;53:358-388.
61. Strauss JS, Stranieri AM, Farrell LN, Downing DT: The effect of marked inhibition of sebum production with 13-cis-retinoic acid on skin surface lipid composition. J Invest Dermatol 1980;74:66-67.
62. Jones H, Blanc D, Cunliffe W: 13-cis-Retinoic acid and acne. Lancet 1980;ii:1048-1049.
63. Landthaler M, Kummermehr J, Wagner A, Plewig G: Inhibitory effects of 13-cis-retinoic acid on human sebaceous glands. Arch Dermatol Res 1980;269:297-309.
64. Geiger J-M, Hommel L, Harms M, Saurat J-H: Oral 13-cis-retinoic acid is superior to 9-cis-retinoic acid in sebosuppression in human beings. J Am Acad Dermatol 1996;34:513-515.
65. Hommel L, Geiger J-M, Harms M, Saurat J-H: Sebum excretion rate in subjects treated with oral all-trans-retinoic acid. Dermatology 1996;193:127-130.
66. Ott F, Bollag W, Geiger J-M: Oral 9-cis-retinoic acid versus 13-cis-retinoic acid in acne therapy. Dermatology 1996;193:124-126.
67. Crettaz M, Baron A, Siegenthaler G, Hunziker W: Ligand specificities of recombinant retinoic acid receptors RARα and RARβ. Biochem J 1990;272:391-397.
68. Siegenthaler G, Saurat J-H: Binding of isotretinoin to cellular retinoic acid-binding protein: A reappraisal; in Marks R, Plewig G (eds): Acne and Related Disorders. London, Dunitz, 1989, pp 169-177.
69. Zouboulis ChC, Korge B, Akamatsu H, Xia L, Schiller S, Gollnick H, Orfanos CE: Effects of 13-cis-retinoic acid, all-trans-retinoic acid and acitretin on the proliferation, lipid synthesis and keratin expression of cultured human sebocytes in vitro. J Invest Dermatol 1991;96:792-797.
70. Doran T, Shapiro SS: Retinoid effects on sebocyte proliferation; in Packer L (ed): Methods in Enzymology. San Diego, Academic Press, 1990, pp 334-338.
71. Shapiro SS, Doran T, Vane F, Eckhoff C, Pacia E, Chari S: Metabolism and antiproliferative effects of natural retinoids in human sebocytes; in Burgdorf WHC, Katz SI (eds): Dermatology - Progress and Perspectives. Proceedings of the 18th World Congress of Dermatology. New York, Parthenon, 1993, pp 188-190.
72. Vane FM, Bugge CJL, Rodriguez LC, Rosenberger M, Doran TI: Human biliary metabolites of isotretinoin: Identification, quantification, synthesis, and biological activity. Xenobiotica 1990;20:193-207.
73. Zouboulis ChC, Korge B, Xia L, Akamatsu H, Gollnick H, Orfanos CE: Wirkungen von Retinoiden auf Proliferation und Differenzierung humaner Talgdrüsenzellen in einem In-vitro-Modell. Z Hautkr 1991;66(suppl 4):23-28.
74. Fasal P: Clinical manifestations of vitamin deficiencies as observed in the Federated Malay States. Arch Dermatol Syphilol 1944;50:160-166.
75. Hume EM, Krebs HA: Vitamin A requirements of human adults: Experimental study of vitamin A deprivation in man: Report of a vitamin A subcommittee of accessory food factors committee. Med Res Counc Spec Rep Ser No 264. London, Her Majesty's Stationery Office, 1949.
76. Frazier CN, Hu CK: Cutaneous lesions associated with a deficiency in vitamin A in man. Arch Intern Med 1931;48:507-514.
77. Hamann K, Avnstorp C: Chronische Hypervitaminose A mit Hautveränderungen. Hautarzt 1982;33:559-561.